HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirokazu Taniguchi Selected Research

Irinotecan (Camptosar)

1/2022Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy.
11/2012[A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy].
11/2011[A case of recurrent gastric cancer successfully treated with radiation therapy].
11/2011[A case of advanced gastric cancer with splenic vein thrombus successfully treated with S-1 plus CPT-11 neoadjuvant chemotherapy].
6/2011Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirokazu Taniguchi Research Topics

Disease

91Neoplasms (Cancer)
01/2022 - 01/2002
51Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2002
28Neoplasm Metastasis (Metastasis)
01/2022 - 04/2002
22Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2007
18Lung Neoplasms (Lung Cancer)
01/2022 - 07/2015
18Adenocarcinoma
12/2020 - 09/2007
14Carcinoma (Carcinomatosis)
02/2021 - 01/2003
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 03/2005
12Lymphatic Metastasis
02/2019 - 01/2002
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 09/2014
10Asthma (Bronchial Asthma)
11/2019 - 05/2002
10Breast Neoplasms (Breast Cancer)
11/2015 - 02/2002
9Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2007
9Adenoma (Adenomas)
04/2020 - 09/2012
8Adenocarcinoma of Lung
01/2022 - 09/2012
7Pneumonia (Pneumonitis)
01/2021 - 07/2003
6Rectal Neoplasms (Rectal Cancer)
12/2021 - 11/2007
5Lymphoma (Lymphomas)
01/2022 - 01/2009
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 12/2010
5Disease Progression
12/2020 - 02/2009
5Chest Pain (Chest Pains)
06/2017 - 11/2007
5Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2016 - 01/2009
4B-Cell Lymphoma (Lymphoma, B Cell)
02/2021 - 10/2004
4Ileus
01/2021 - 10/2003
4Fibrosis (Cirrhosis)
04/2020 - 11/2013
4Polyps
04/2020 - 10/2017
4Brain Neoplasms (Brain Tumor)
01/2019 - 04/2002
4Carcinogenesis
01/2018 - 01/2002
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2016 - 01/2009
4Tuberculosis (Tuberculoses)
02/2009 - 08/2003
3Edema (Dropsy)
01/2022 - 11/2013
3Obesity
01/2022 - 01/2016
3Thrombosis (Thrombus)
12/2021 - 11/2011
3Febrile Neutropenia
09/2021 - 12/2010
3Residual Neoplasm
01/2021 - 02/2009
3Pleural Effusion (Pleural Effusions)
01/2020 - 02/2009
3Neutropenia
11/2019 - 12/2010
3Melanoma (Melanoma, Malignant)
11/2018 - 07/2008
3Hemorrhage
11/2018 - 09/2013
3Fever (Fevers)
04/2017 - 07/2003
3Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
03/2017 - 08/2016

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
12/2021 - 10/2003
13Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2002
10Biomarkers (Surrogate Marker)IBA
02/2021 - 07/2006
9Pharmaceutical PreparationsIBA
01/2022 - 05/2011
9Rituximab (Mabthera)FDA Link
02/2021 - 01/2009
8amrubicinIBA
10/2022 - 09/2014
7Prednisolone (Predate)FDA LinkGeneric
01/2021 - 07/2003
6Anaplastic Lymphoma KinaseIBA
01/2022 - 06/2014
6Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2013
6osimertinibIBA
10/2021 - 12/2017
6Adrenal Cortex Hormones (Corticosteroids)IBA
04/2017 - 05/2002
6Formaldehyde (Formol)FDA Link
11/2016 - 01/2013
6ParaffinIBA
11/2016 - 01/2013
6Paclitaxel (Taxol)FDA LinkGeneric
04/2011 - 02/2002
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 11/2014
5Irinotecan (Camptosar)FDA LinkGeneric
01/2022 - 06/2011
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 04/2002
5Docetaxel (Taxotere)FDA Link
01/2020 - 04/2011
5Trastuzumab (Herceptin)FDA Link
02/2019 - 08/2014
5NivolumabIBA
01/2019 - 11/2017
5CrizotinibIBA
01/2019 - 06/2014
5Fluorouracil (Carac)FDA LinkGeneric
05/2017 - 11/2002
5AcidsIBA
01/2016 - 08/2003
4Etoposide (VP 16)FDA LinkGeneric
10/2022 - 12/2010
4Capecitabine (Xeloda)FDA Link
01/2022 - 10/2014
4fibroblast growth factor 21IBA
01/2022 - 10/2014
4RNA (Ribonucleic Acid)IBA
05/2021 - 12/2003
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2010
4Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2010
4theasinensin AIBA
04/2020 - 10/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2007
4Bevacizumab (Avastin)FDA Link
01/2020 - 11/2010
4Carcinoembryonic AntigenIBA
11/2019 - 11/2003
4Bronchodilator Agents (Bronchodilators)IBA
11/2019 - 09/2009
4Epstein-Barr virus encoded RNA 1IBA
07/2019 - 01/2013
4Phosphotransferases (Kinase)IBA
01/2019 - 11/2009
4Estrogen ReceptorsIBA
11/2014 - 11/2011
4Progesterone Receptors (Progesterone Receptor)IBA
11/2014 - 11/2011
4Messenger RNA (mRNA)IBA
09/2007 - 10/2003
3Carboplatin (JM8)FDA LinkGeneric
10/2022 - 09/2014
3Immune Checkpoint InhibitorsIBA
01/2022 - 10/2018
3Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 09/2009
3ErbB Receptors (EGF Receptor)IBA
02/2021 - 01/2017
3S-1 plus cisplatinIBA
02/2019 - 10/2014
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019 - 07/2017
3LigandsIBA
01/2018 - 07/2006
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2017 - 01/2016

Therapy/Procedure

49Drug Therapy (Chemotherapy)
01/2022 - 10/2003
46Therapeutics
01/2022 - 02/2002
19Gastrectomy
12/2021 - 10/2003
12Radiotherapy
01/2022 - 11/2010
12Lymph Node Excision (Lymph Node Dissection)
12/2021 - 01/2009
10Neoadjuvant Therapy
01/2021 - 11/2011
7Adjuvant Chemotherapy
12/2021 - 11/2007
7Colectomy
11/2016 - 08/2010
5Esophagectomy
01/2020 - 07/2008
5Chemoradiotherapy
11/2017 - 11/2010
4Combination Drug Therapy (Combination Chemotherapy)
06/2022 - 10/2014
3Lasers (Laser)
01/2019 - 09/2012